Lawsuit Information CenterOur lawyers handle Paraquat lawsuits in all 50 states. This page provides the latest news and updates on Paraquat lawsuits in both state and federal courts. We also give our perspective on where this litigation is heading and provide projected settlement payouts for a viable Paraquat lawsuit.
Articles Posted in Mass Torts
Bard PowerPort Lawsuit
Bard PowerPort lawsuits allege that defects in implanted port catheters can cause fractures, migration, blood clots, infections, embolisms, and other serious complications. Thousands of product liability lawsuits are now pending against Bard and its parent company, Becton Dickinson, in a federal multidistrict litigation in Arizona. After a long slog, these cases are now moving forward.
The first bellwether trial ended with a partial defense verdict and a deadlocked jury on the central design defect claim. The most recent trial, Divelbliss v. C.R. Bard, led to a $40 million verdict. It involved an alleged fracture of a silicone Groshong catheter. Five bellwether trials are now expected to run through February 2027. So far, we are 1-1, with the third trial now getting underway. Our lawyers remain bullish on well-documented fracture, migration, and embolization cases.
This page provides the latest Bard PowerPort lawsuit updates, projected settlement amounts, and information about who may qualify to file a claim.
Baby Food Autism Lawsuit
Our law firm is handling baby food autism lawsuits in all 50 states.
Several popular brands of baby food contain high levels of heavy metals such as mercury, arsenic, lead, and cadmium. These heavy metals are well-known neurotoxins. Thousands of children may have developed autism and other neurodevelopmental disorders due to toxic metals found in baby foods.
A growing number of parents are pursuing a toxic baby food lawsuit to hold manufacturers accountable for their children’s exposure to harmful contaminants. These baby food autism lawsuits allege the manufacturers knew about heavy metals in their products, and children developed autism from consuming them.
Breast Mesh Lawsuits and Internal Bra Complications
Breast mesh lawsuits allege that some manufacturers promoted or allowed their mesh products to become widely used in breast reconstruction, augmentation, and revision procedures despite the fact that FDA has not cleared or approved any surgical mesh product for use in breast surgery. The FDA has specifically stated that the safety and effectiveness of surgical mesh in breast surgery, including augmentation and reconstruction, has not been determined.
These internal bra lawsuits allege that manufacturers of products such as AlloDerm, GalaFLEX, Phasix, AlloMax, FlexHD, Strattice, and DuroSorb marketed their devices for breast reconstruction, augmentation, and revision surgeries even though those breast-specific applications had not been adequately studied or cleared by the FDA. Patients were not warned. Surgeons were not given enough information. So when complications developed, including infection, mesh failure, chronic pain, implant loss, breast deformity, and the need for additional surgery, many women had no reason to connect their injuries to the mesh product placed inside them.
Chlorpyrifos Parkinson’s Disease Lawsuits
Chlorpyrifos lawsuits allege that repeated exposure to this widely used insecticide can contribute to Parkinson’s disease. The people most likely to bring these claims are farmers, pesticide applicators, pest control workers, groundskeepers, greenhouse employees, and others who personally mixed, loaded, sprayed, or cleaned up chlorpyrifos products over months or years.
Chlorpyrifos was sold under trade names that include Dursban, Lorsban, Cobalt, Nufos, Bolton, Stallion, Pilot, Warhawk, and Hatchet. It was used on farms, golf courses, ornamental plants, and residential and commercial properties. Many workers remember the trade name but not the active ingredient. Product identification is therefore one of the first and most important parts of investigating a claim.
Quick answers
Monsanto Roundup Lawsuit Update
In this post, our Roundup lawyers will give you:
- An update on where things stand in the new $7.5 billion Roundup class action lawsuit settlement in October 2026
- The likely direction the Roundup litigation will take moving forward, and
Depo Provera Lawsuit Settlements
This page is for women considering filing a Depo-Provera lawsuit. Our lawyers provide the latest updates, explain the litigation and settlement process, and offer our assessment of potential Depo-Provera settlement amounts.
Scientific research has found a strong association between prolonged use of injectable medroxyprogesterone acetate, the active drug in Depo-Provera, and intracranial meningioma. Women who received Depo-Provera injections and were later diagnosed with a meningioma are filing lawsuits alleging that Pfizer and related companies failed to provide an adequate warning.
Paragard IUD Lawsuit Settlement Amounts
Our lawyers are handling Paragard IUD lawsuits for women throughout the United States. These cases allege that the copper IUD can fracture during removal, leaving one or both plastic arms inside the uterus and sometimes forcing the patient to undergo another procedure or surgery.
The federal litigation now includes more than 4,000 filed cases. The first bellwether trial ended in a defense verdict in February 2026. That was a real loss for plaintiffs, and it changed the settlement calculus maybe a bit. But it is just one case, and we can turn it around with a win in April 2027 at the next trial.
So there is no Paragard settlement deal as of October 2026. Our lawyers still believe these claims will eventually be resolved through a negotiated settlement, but the first defense verdict makes it harder to predict when that could happen or what defendants will be willing to pay. We discuss our estimated Paragard settlement values below.
Spinal Cord Stimulator Lawsuit
A spinal cord stimulator is an implantable medical device used to manage chronic pain, most often involving the back or spine. These systems are marketed as a way to reduce pain by interrupting nerve signals before they reach the brain. But for a growing number of patients, the device fails to help. It introduces new and sometimes permanent problems, including electrical shocks, burning pain, infections, lead migration, hardware failure, and repeat surgeries to reposition or remove equipment that was supposed to improve quality of life.
This page explains spinal cord stimulator lawsuits and why they are being filed nationwide. It focuses on what patients are alleging, how these devices have failed in real-world use, and why many of these cases go beyond ordinary medical malpractice claims. The most serious lawsuits do not center on a single surgical mistake. They examine how modern spinal cord stimulators were designed, tested, and approved, and whether patients were ever adequately warned about the risks that now recur repeatedly in medical records and FDA reports.
Many victims want to know what spinal cord stimulator settlement amounts will look like, and how we think compensation will be calculated, assuming there is an ultimate settlement. Settlement amounts and payouts in these cases will depend on several factors, which we dig into more fully below.
Ozempic Lawsuit
Our lawyers are investigating Ozempic lawsuits for patients with NAION, gastroparesis, or gastrointestinal conditions, including bowel obstruction or cyclic vomiting syndrome.
Ozempic is the popular brand name for semaglutide, a prescription drug approved for the treatment of type 2 diabetes. As we all know, Ozempic is also commonly used as a weight management drug. Recent scientific studies have shown that taking Ozempic, particularly at higher doses, can cause gastroparesis.